Raleigh Capital Management’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$947K Sell
3,730
-26
-0.7% -$6.06K 0.3% 88
2026
Q1
$918K Sell
3,756
-7,912
-68% -$1.84M 0.32% 89
2025
Q4
$2.41M Sell
11,668
-4,297
-27% -$850K 0.88% 29
2025
Q3
$2.96M Buy
15,965
+1,188
+8% +$204K 1.13% 18
2025
Q2
$2.26M Buy
14,777
+1,005
+7% +$154K 0.95% 19
2025
Q1
$2.28M Sell
13,772
-1,001
-7% -$157K 1.03% 17
2024
Q4
$2.14M Buy
14,773
+4,810
+48% +$745K 0.82% 26
2024
Q3
$1.61M Buy
9,963
+3,859
+63% +$615K 0.62% 46
2024
Q2
$892K Sell
6,104
-383
-6% -$57K 0.38% 80
2024
Q1
$1.03M Buy
6,487
+1
+0% +$159 0.44% 68
2023
Q4
$1.02M Sell
6,486
-1,041
-14% -$160K 0.47% 67
2023
Q3
$1.17M Buy
7,527
+1,593
+27% +$263K 0.6% 59
2023
Q2
$982K Sell
5,934
-221
-4% -$35.7K 0.49% 69
2023
Q1
$954K Buy
6,155
+469
+8% +$75.7K 0.47% 71
2022
Q4
$1M Buy
5,686
+123
+2% +$21.2K 0.52% 60
2022
Q3
$909K Buy
5,563
+175
+3% +$29.6K 0.53% 59
2022
Q2
$956K Buy
5,388
+852
+19% +$152K 0.54% 55
2022
Q1
$804K Buy
4,536
+4,458
+5,715% +$759K 0.44% 68
2021
Q4
$13K Buy
+78
New +$12.8K 0.01% 180

Other funds holding JNJ

Raleigh Capital Management's JNJ Position: Q2 2026 in Review

Raleigh Capital Management reduced its Johnson & Johnson (JNJ) stake by 0.69% in Q2 2026, selling an estimated $6.06K and leaving 3,730 shares worth $947K. The position accounts for 0.3% of the portfolio, ranked #88.

Raleigh Capital Management first reported a position in JNJ in Q4 2021 and has held it in 19 quarters since. The position peaked at $2.96M in Q3 2025. 4,665 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Raleigh Capital Management held 3,730 shares of Johnson & Johnson worth $947K as of Q2 2026.
  • Raleigh Capital Management sold 26 Johnson & Johnson shares in Q2 2026, an estimated $6.06K.
  • Johnson & Johnson made up 0.3% of Raleigh Capital Management's portfolio in Q2 2026, its #88 holding.
  • Raleigh Capital Management first reported a position in Johnson & Johnson in Q4 2021 and has held it in 19 quarters since.
  • Raleigh Capital Management's Johnson & Johnson position peaked at $2.96M in Q3 2025.
  • 4,665 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Raleigh Capital Management's 13F filing for Q2 2026, filed 21 Jul 2026.